CRISPR-Cas 9 can be used to target the HIV-5′LTR, which is the promoter region, therefore preventing the replication or activation of the latent virus; the CCR5 or CXCR4 region, rendering the cells resistant to infection; or restriction factors that promote HIV replication, to block their activity [223]. This evidence concerns the gene CCR5 and infection.